2,2-bis(4-glycidyloxyphenyl)propane has been researched along with troglitazone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fowler, R; Friday, E; Nissim, I; Turturro, F; Welbourne, T | 1 |
| Cho, DH; Choi, YJ; Jo, I; Jo, SA | 1 |
| Bae, HK; Cheong, HT; Jung, BD; Lee, S; Park, CK; Yang, BK | 1 |
3 other study(ies) available for 2,2-bis(4-glycidyloxyphenyl)propane and troglitazone
| Article | Year |
|---|---|
Troglitazone acts by PPARgamma and PPARgamma-independent pathways on LLC-PK1-F+ acid-base metabolism.
Topics: Acid-Base Equilibrium; Acidosis; Alanine; Alkaloids; Animals; Antineoplastic Agents; Benzhydryl Compounds; Benzophenanthridines; Carcinogens; Chromans; Enzyme Inhibitors; Epoxy Compounds; Genes, Reporter; Hydrogen-Ion Concentration; LLC-PK1 Cells; Phenanthridines; Plasmids; Protein Kinase C; Quaternary Ammonium Compounds; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Swine; Thiazolidinediones; Transcription Factors; Troglitazone | 2004 |
Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent s
Topics: Animals; Benzhydryl Compounds; Cattle; Chromans; Endothelium, Vascular; Enzyme Activation; Epoxy Compounds; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphorylation; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazolidinediones; Transcription Factors; Troglitazone; Up-Regulation; Vasodilator Agents | 2004 |
Correlation of spontaneous adipocyte generation with osteogenic differentiation of porcine skin-derived stem cells.
Topics: Adipocytes; Animals; Benzhydryl Compounds; Cell Differentiation; Cell Line; Epoxy Compounds; Female; Osteogenesis; Skin; Stem Cells; Sus scrofa; Troglitazone | 2019 |